Reimbursement process begins in Switzerland, Germany for GI Dynamics' EndoBarrier

October 3, 2013 by Brad Perriello

Regulators in Switzerland and Germany take the 1st steps toward reimbursement for GI Dynamics' flagship EndoBarrier device to treat obesity and Type II diabetes.

Reimbursement process begins in Switzerland, Germany for GI Dynamics' EndoBarrier

GI Dynamics (ASX:GID) said Swiss and German regulators took the 1st steps toward reimbursement in those countries for its EndoBarrier weight loss and diabetes device.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp